# Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly

> **NCT06309225** · NA · RECRUITING · sponsor: **Omar Mahmoud** · enrollment: 20 (estimated)

## Conditions studied

- Oropharynx Cancer
- Frailty

## Interventions

- **RADIATION:** Modified dose and fields intensity modulated radiotherapy

## Key facts

- **NCT ID:** NCT06309225
- **Lead sponsor:** Omar Mahmoud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309225, "Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06309225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*